SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 105.43+1.2%12:57 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (955)3/29/1999 8:23:00 AM
From: Mike McFarland  Read Replies (1) of 3202
 
Someday soon these guys will grab their incy and
a smattering of the other first tier gene stocks
("genomics, bioinformatics, pharmacogenetics...").
I have seen earnings estimates for incy at around
break-even this year, and fifty cents next year--
but quite a range, from zero to a buck for 2000.
I wish Value Line would pick up coverage of INCY,
HGSI is the only one they cover, and that one looks
expensive compared to INCY with growing losses for
a few years...

___
DAK:

Regarding Fidelity, I have to say that I've whined
on these threads about the rapid turnover of fund
managers there (Mr. Kaul is coming up on his one
year aniversary working for that fund in June)
but this fellow has done well, as far as I
can tell he is leading the pack of bio funds and
Lipper puts him near the top.

FBIOX:
Top Ten Holdings as of 12/31/1998
AMGEN INC
GENENTECH INC SPECIAL COMMON
BIOGEN INC
CHIRON CORP
GENZYME CORP-GENERAL DIVISION
MEDIMMUNE INC
FOREST LABORATORIES INC
SEPRACOR INC
MERCK & CO INC
SCHERING PLOUGH

58.8% of the portfolio

Lipper Ranking as of 2/28/1999
1 Year #3 out of 46 Health/Biotechnology
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext